What is this study trying to understand?
Based on the public registry summary, this study is trying to understand: The current study aims to evaluate the sensitivity and specificity of a combination of various objective biomarkers for the diagnosis of PTSD. The study team can confirm the exact objective and what it means for you.
Does this study involve biological samples, imaging, or biomarkers?
This appears to be a biological / biomarker / imaging study involving CAPS questionnaire, Beck Depression Inventory, The Fibromyalgia Impact Questionnaire, The Pittsburgh Sleep Quality Index, Depression, Anxiety and Stress Scale-21 items, Traumatic Events Questionnaire, Clinician Administered Dissociative States Scale, A diary will be used for seven consecutive nights, MRI, Functional brain imaging, EEG analysis, Autonomic nervous system monitors. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.
Who might this study be for?
This study may concern people with ptsd; age range: From 20 Years to 60 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to provide biological samples, complete lab tests, or take part in imaging or measurement procedures. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What should I check about samples, imaging, data, and possible discomfort?
If the study involves samples, imaging, or biomarkers, ask what is collected, how it is stored, who can access results, whether there may be discomfort, and whether results are shared with you. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Assaf-Harofeh Medical Center, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
Current recruitment is not confirmed. Check the official registry or contact the research team before making plans to participate.
